CATTANEO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 22.262
EU - Europa 21.047
AS - Asia 5.130
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 96
AF - Africa 25
OC - Oceania 23
Totale 48.939
Nazione #
US - Stati Uniti d'America 22.158
IT - Italia 7.366
SE - Svezia 3.882
IE - Irlanda 3.211
TR - Turchia 1.719
DE - Germania 1.633
CN - Cina 1.539
UA - Ucraina 1.512
SG - Singapore 1.311
GB - Regno Unito 936
FI - Finlandia 572
NL - Olanda 438
CH - Svizzera 411
RU - Federazione Russa 390
BR - Brasile 312
AT - Austria 289
VN - Vietnam 163
BE - Belgio 128
FR - Francia 98
EU - Europa 92
CA - Canada 87
IL - Israele 82
ID - Indonesia 66
JP - Giappone 50
IN - India 30
ES - Italia 28
AE - Emirati Arabi Uniti 25
HK - Hong Kong 23
KR - Corea 22
AU - Australia 21
RO - Romania 18
AL - Albania 16
PK - Pakistan 13
BD - Bangladesh 11
MX - Messico 11
NO - Norvegia 11
PL - Polonia 11
BG - Bulgaria 10
CZ - Repubblica Ceca 10
DK - Danimarca 10
HU - Ungheria 10
IR - Iran 10
RS - Serbia 10
IQ - Iraq 9
AR - Argentina 8
LT - Lituania 8
CL - Cile 7
LU - Lussemburgo 7
TW - Taiwan 7
ZA - Sudafrica 7
CO - Colombia 6
EC - Ecuador 6
MA - Marocco 6
VE - Venezuela 6
GR - Grecia 5
PE - Perù 5
EG - Egitto 4
JO - Giordania 4
LK - Sri Lanka 4
MT - Malta 4
NP - Nepal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IM - Isola di Man 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
LI - Liechtenstein 3
PA - Panama 3
PH - Filippine 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GL - Groenlandia 1
HN - Honduras 1
KE - Kenya 1
KZ - Kazakistan 1
Totale 48.931
Città #
Pisa 5.592
Jacksonville 3.404
Chandler 3.259
Dublin 3.206
Boardman 2.127
Wilmington 1.347
Izmir 1.301
Ashburn 1.287
Singapore 937
Ann Arbor 928
Boston 713
Millbury 681
Düsseldorf 520
San Mateo 462
Istanbul 407
New York 401
Amsterdam 381
Bern 367
Mestre 367
Bremen 320
Lawrence 314
Ogden 295
Seattle 291
Vienna 277
Woodbridge 235
Beijing 215
Princeton 204
Washington 178
Scuola 177
Dearborn 172
Saint Petersburg 167
Dong Ket 163
Milan 137
Helsinki 134
Brussels 124
Guangzhou 122
San Paolo di Civitate 114
Munich 104
Shanghai 97
Los Angeles 84
Rome 83
Fairfield 81
Santa Clara 81
Wuhan 72
Holon 69
Jakarta 66
Norwalk 60
Toronto 57
Hefei 56
Nanjing 53
San Giuliano Terme 51
Las Vegas 45
Andover 42
Houston 41
Kunming 41
Tokyo 40
Falls Church 39
Berlin 38
Cambridge 34
Chicago 34
Bientina 33
Verona 32
Jiaxing 31
Frankfurt am Main 26
Tappahannock 26
Ferrara 24
Wuxi 24
Lausanne 23
Nanchang 23
Shenzhen 23
Jinhua 22
Livorno 22
London 22
San Diego 22
Florence 21
Padova 21
Voghera 21
São Paulo 20
Yiwu 19
Edinburgh 18
Trieste 18
Jinan 17
Seoul 15
Madrid 14
Paris 14
Stockholm 14
Zurich 14
Fuzhou 13
Hangzhou 13
Heze 13
Shenyang 13
Zhengzhou 13
Auburn Hills 12
Centrale 12
Hanover 12
Nuremberg 12
Redmond 12
Cedar Knolls 11
Hong Kong 11
Belo Horizonte 10
Totale 33.430
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.419
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration 1.025
A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists 935
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 217
Precursor and mature NGF live tracking: one versus many at a time in the axons 209
Site-specific labeling of neurotrophins and their receptors via short and versatile peptide tags 187
A new intramolecular biosensor reveals Tau conformational changes in pathological conditions 179
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 177
Activity-dependent expression of Channelrhodopsin at neuronal synapses 176
Assessment of antibody library diversity through next generation sequencing and technical error compensation 176
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 172
Ligand signature in the membrane dynamics of single TrkA receptor molecules 169
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 169
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 169
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 159
Fast-diffusing p75NTR monomers support apoptosis and growth cone collapse by neurotrophin ligands 158
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 158
Ligand-induced dynamics of neurotrophin receptors investigated by single-molecule imaging approaches 156
Corrigendum: Precursor and mature NGF live tracking: one versus many at a time in the axons 155
Site-specific biotinylation of neurotrophins and their receptors by the insertion of short versatile peptide tags 152
Single particle tracking of acyl carrier protein (ACP)-tagged TrkA receptors in PC12nnr5 cells 150
Ligand Fingerprinting in the Membrane Dynamics of Single TrkA and P75NTR Neurotrophin Receptors 148
An Optimized Procedure for the Site-Directed Labeling of NGF and proNGF for Imaging Purposes 148
Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells 146
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 146
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 145
NGF steers microglia toward a neuroprotective phenotype 142
Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies 142
Purification and proteomic profiling of PSD-95 intereactors at in vivo potentiated synapses 139
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 139
In vivo expression of anti-tau intrabodies selected by the intrabody trap technology (ITT). 137
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization 137
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate 137
Structural and functional properties of mouse proNGF 136
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 136
Mapping potentiated synapses in the hippocampus during acquisition and consolidation of a contextual fear memory 136
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 136
A functional domain on the aloha-latrotoxin molecule, distinct from the binding site, involved in cathecolamine secretion from PC12 cells: identification with monoclonal antibodies 134
TANEZUMAB, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain 133
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 133
Single Molecule Imaging and Tracking of Neurotrophins and their Receptors in Living Neuronal Cells 132
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells 132
IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels 130
null 129
A protein silencing switch by ligand-induced proteasome targeting intrabodies 129
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 128
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 127
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 127
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 125
Alpha-synuclein fret biosensors reveal early alpha-synuclein aggregation in the endoplasmic reticulum 125
A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites 124
Temperature affects longevity and age-related locomotor and cognitive decay in the short-lived fish Nothobranchius furzeri 123
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 123
Single molecule tracking and spectroscopy unveils molecular details in function and interactions of membrane receptors 123
Large differences in aging phenotype between strains of the short-lived annual fish Nothobranchius furzeri 122
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 121
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 121
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 120
A new mechanism for Alzheimer Neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 120
Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor 120
Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice 119
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 118
The role of Nerve Growth Factor in development and in ALzheimer's disease 118
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 118
Novel recombinant antibodies against AD biomarkers linked to neurotrophin signaling as potential diagnostic tools. 117
Kinetic dynamics of a kinase-phosphatase network 117
RACK1 Is a Ribosome Scaffold Protein for beta-actin mRNA/ZBP1 Complex 117
A new generation of NGF-based therapy for Alzheimer’s disease 117
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 117
Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study 116
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 116
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 116
Novel generation of neutralizing antibodies against beta-Amyloid peptide 115
'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants 115
In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an “undruggable” class of disease targets 114
Thymocytes as potential target cells for nerve growth factor 114
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 114
Cholinesterase inhibitors with nicotinic mode of action: Neuroprotection in anti-NGF mice 114
Conformational targeting of intracellular Amyloid-beta oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum 114
“Annual fishes of the genus Nothobranchius as a model system for aging research” 113
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 113
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 113
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 113
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 112
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 112
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 112
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 112
Involvement of NGF in early stages of chick embryo development 112
Method for the humanization of antibodies and humanized antibodies thereby obtained 111
Intranasal delivery of therapeutic proteins for neurological diseases 111
Patterns of discharge of simple and complex visual cortical cells. 110
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 110
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 109
Inflammatory responses in anti-Nerve Growth Factor transgenic mice 109
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 109
Novel fluorescent cycloheximide derivatives for the imaging of protein synthesis 108
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 108
TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor 108
A critical period in the sensitivity of basal forebrain cholinergic neurones to NGF deprivation 108
Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat 108
Totale 17.145
Categoria #
all - tutte 216.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.237 0 0 0 0 0 0 0 146 490 87 485 29
2020/20216.222 492 41 1.183 39 462 517 307 490 501 1.146 347 697
2021/20223.691 387 30 40 241 245 67 82 336 247 203 126 1.687
2022/202315.413 1.024 827 600 1.087 925 1.530 9 3.998 4.737 91 241 344
2023/20244.857 793 128 507 144 283 990 186 200 599 170 36 821
2024/20259.245 2.304 385 657 1.976 2.130 320 1.472 1 0 0 0 0
Totale 49.631